Cargando…
Repurposing the Pathogen Box compounds for identification of potent anti-malarials against blood stages of Plasmodium falciparum with PfUCHL3 inhibitory activity
Malaria has endured as a global epidemic since ages and its eradication poses an immense challenge due to the complex life cycle of the causative pathogen and its tolerance to a myriad of therapeutics. PfUCHL3, a member of the ubiquitin C-terminal hydrolase (UCH) family of deubiquitinases (DUBs) is...
Autores principales: | Bharti, Hina, Singal, Aakriti, Saini, Manisha, Cheema, Pradeep Singh, Raza, Mohsin, Kundu, Suman, Nag, Alo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766476/ https://www.ncbi.nlm.nih.gov/pubmed/35042884 http://dx.doi.org/10.1038/s41598-021-04619-4 |
Ejemplares similares
-
Artemisinin Mediates Its Tumor-Suppressive Activity in Hepatocellular Carcinoma Through Targeted Inhibition of FoxM1
por: Nandi, Deeptashree, et al.
Publicado: (2021) -
Exploring the therapeutic potential of forkhead box O for outfoxing COVID-19
por: Cheema, Pradeep Singh, et al.
Publicado: (2021) -
Crystal structure of the aquaglyceroporin PfAQP from the malarial parasite Plasmodium falciparum
por: Newby, Zachary E R, et al.
Publicado: (2008) -
Molecular dynamics simulations of PfAQP from the malarial parasite Plasmodium falciparum
por: CUI, YUBAO, et al.
Publicado: (2012) -
PfMDR2 and PfMDR5 are dispensable for Plasmodium falciparum asexual parasite multiplication but change in vitro susceptibility to anti-malarial drugs
por: van der Velden, Maarten, et al.
Publicado: (2015)